The XBP1 Gene Major Affective Disorder 7 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect genetic variations in the XBP1 gene that are associated with an increased risk of developing major affective disorders, including major depression and bipolar disorder. This test is particularly valuable for individuals with a family history of these conditions or those experiencing symptoms, as it can provide critical insights into their genetic predisposition. The process involves a simple DNA sample collection, typically through a blood draw or cheek swab, which is then analyzed for specific genetic markers linked to affective disorders.
The cost of the XBP1 Gene Major Affective Disorder 7 Genetic Test at DNA Labs UAE is 4400 AED. This investment in personal health allows individuals to gain a deeper understanding of their genetic makeup and its potential impact on their mental health. The results from this test can guide healthcare providers in developing more personalized and effective treatment plans, taking into account the genetic factors that may influence the course of the disorder. Additionally, it empowers individuals with actionable insights to make informed decisions about their mental health management and preventive strategies.
TUBB4A Gene Leukodystrophy, Hypomyelinating Type 6, is a rare genetic disorder characterized by abnormalities in the development and maintenance of the myelin sheath, the protective covering of nerve cells. This condition leads to a range of neurological symptoms, including muscle stiffness, movement disorders, and developmental delays. The TUBB4A gene plays a crucial role in the proper formation of microtubules, essential components for cell structure and function, including in the nervous system.
To diagnose this condition, a genetic test targeting the TUBB4A gene can be conducted. DNA Labs UAE offers this specialized genetic test, designed to detect mutations in the TUBB4A gene that are responsible for Hypomyelinating Leukodystrophy Type 6. The test is a critical step for accurate diagnosis, allowing for a better understanding of the condition and facilitating tailored management and treatment plans for affected individuals.
The cost of the TUBB4A Gene Leukodystrophy hypomyelinating type 6 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the specific genetic alterations within the TUBB4A gene, providing essential information for affected families and their healthcare providers. By confirming a diagnosis through genetic testing, families can gain insights into the condition, its progression, and potential interventions to improve quality of life.
The POLR3A Gene Leukodystrophy Hypomyelinating Type 7 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the POLR3A gene, which are associated with Hypomyelinating Leukodystrophy Type 7 (HLD7). This condition is a rare genetic disorder characterized by the underdevelopment of the white matter in the brain, leading to a range of neurological symptoms such as delayed development, muscle stiffness, and difficulty coordinating movements. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect abnormalities in the POLR3A gene, providing crucial information for accurate diagnosis and potential treatment options. By identifying the genetic basis of the condition, healthcare providers can offer more personalized care plans and support for affected individuals and their families.
The POLR3B Gene Leukodystrophy hypomyelinating type 8 Genetic Test is a specialized diagnostic examination aimed at identifying mutations in the POLR3B gene, which are linked to a rare form of leukodystrophy known as hypomyelinating leukodystrophy type 8. This condition is characterized by a significant reduction in the white matter in the brain, which affects the myelin sheath, the material that surrounds and protects nerve fibers. As a result, individuals with this condition often experience a range of neurological symptoms, including motor and cognitive impairments.
The test is performed by DNA Labs UAE, a leading genetic testing facility in the United Arab Emirates known for its state-of-the-art technology and expertise in genetic diagnostics. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and detailed reporting provided by the lab. This test is crucial for families seeking answers about this genetic condition, as it not only confirms the diagnosis but also helps in understanding the disease progression, potential treatments, and management strategies. It is a vital tool in the field of personalized medicine, offering hope and support to affected individuals and their families.
Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) is a rare genetic disorder caused by mutations in the DARS2 gene. This condition is characterized by changes in the white matter of the brain, specifically affecting the brainstem and spinal cord, and is often associated with elevated lactate levels, indicating a disruption in cellular energy production. Symptoms can include difficulties with movement and coordination, muscle stiffness, and developmental delays, among others.
To diagnose this condition, a genetic test targeting the DARS2 gene can be performed. This test involves analyzing the DNA to identify mutations in the DARS2 gene that are responsible for LBSL. It is a crucial step for confirming the diagnosis, understanding the disease's progression, and potentially guiding treatment options.
At DNA Labs UAE, this specialized genetic test for identifying DARS2 gene mutations associated with LBSL is available. The cost of the test is 4400 AED. Conducting the test in a reputable laboratory like DNA Labs UAE ensures accuracy and reliability of the results, providing essential information for patients and their families to manage the condition effectively.
The "SCP2 Gene Leukoencephalopathy with Dystonia and Motor Neuropathy Genetic Test" is a specialized diagnostic evaluation available at DNA Labs UAE, designed to identify mutations in the SCP2 gene, which are implicated in the development of leukoencephalopathy with dystonia and motor neuropathy. This condition is a rare neurological disorder characterized by changes in the brain's white matter, leading to dystonia (involuntary muscle contractions), motor neuropathy (nerve damage affecting muscle control), and a range of other neurological symptoms.
The test is crucial for individuals showing symptoms of the disorder or those with a family history, as it helps in confirming the diagnosis, understanding the progression of the disease, and planning appropriate management and treatment strategies. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect mutations in the SCP2 gene.
At DNA Labs UAE, this comprehensive genetic test is offered at a cost of 4400 AED. The price reflects the sophisticated technology and expertise required to accurately identify the genetic alterations associated with this complex condition. The results from this test can provide essential insights for affected individuals and their families, guiding clinical decisions and offering information on the genetic risk for future generations.
The EIF2B2 gene plays a critical role in the regulation of protein synthesis within cells and is particularly significant in the context of neurological development and function. Mutations in this gene are associated with leukoencephalopathy with vanishing white matter (VWM), a rare and progressive condition characterized by the deterioration of white matter in the brain. This deterioration leads to symptoms such as spasticity, ataxia, seizures, and cognitive decline, typically triggered or worsened by febrile infections or minor head trauma.
To diagnose this condition, genetic testing for mutations in the EIF2B2 gene, among others, is crucial. DNA Labs UAE offers a comprehensive genetic test targeting the EIF2B2 gene to confirm the diagnosis of leukoencephalopathy with vanishing white matter. This test is essential for individuals displaying symptoms of VWM, or for families with a history of the condition seeking a definitive diagnosis.
The test is priced at 4400 AED, reflecting the advanced technology and expertise required to accurately identify mutations in the EIF2B2 gene. Conducted in a state-of-the-art laboratory by experienced geneticists, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for specific genetic alterations known to cause VWM.
This genetic test not only facilitates an accurate diagnosis but also helps in understanding the progression of the disease, informing treatment decisions, and providing essential information for family planning. Given the complexity and rarity of VWM, access to such precise genetic testing at DNA Labs UAE represents a critical step forward for affected individuals and their families, offering hope for better management and understanding of the condition.
The EIF2B4 gene is associated with a rare genetic disorder known as Leukoencephalopathy with Vanishing White Matter (VWM). This condition affects the brain's white matter, leading to a progressive loss of motor and cognitive functions. The EIF2B4 gene plays a crucial role in protein synthesis and its mutations can disrupt normal brain development and function, leading to the symptoms observed in VWM.
Genetic testing for mutations in the EIF2B4 gene can confirm a diagnosis of VWM, providing essential information for the management and treatment of the condition. The test involves analyzing the patient's DNA to identify mutations in the EIF2B4 gene that are known to cause the disorder.
At DNA Labs UAE, a specialized genetic test for the EIF2B4 gene associated with Leukoencephalopathy with Vanishing White Matter is available. The cost of the test is 4400 AED. This test is crucial for families seeking a definitive diagnosis, enabling them to understand the condition better, make informed decisions about care and management, and assess the risk for future children. It's also a step forward in the pursuit of personalized medicine, offering hope for targeted therapies in the future.
The EIF2B5 gene leukoencephalopathy with vanishing white matter is a rare genetic disorder that affects the brain's white matter, leading to a progressive loss of brain function. This condition is caused by mutations in the EIF2B5 gene, which plays a crucial role in protein synthesis and the stress response in cells. Symptoms of this disorder can include motor dysfunction, coordination problems, spasticity, and in severe cases, coma or death. Early diagnosis is vital for managing symptoms and improving the quality of life.
To diagnose this condition, a genetic test is available at DNA Labs UAE, specifically targeting the EIF2B5 gene to identify mutations responsible for the disorder. The test cost is set at 4400 AED. This specialized testing is crucial for families seeking answers about this condition, offering them the possibility of genetic counseling and the potential for targeted therapies. The test is performed in a state-of-the-art facility, ensuring accurate and reliable results for those affected by this challenging condition.
The RNASET2 gene leukoencephalopathy cystic without megalencephaly is a rare genetic disorder characterized by changes in the white matter of the brain, specifically the development of cysts without an increase in brain size (megalencephaly). This condition can lead to a range of neurological symptoms and challenges. The genetic basis of this disorder involves mutations in the RNASET2 gene, which plays a role in various cellular processes including the response to viral infections and the regulation of inflammation.
To diagnose this condition, genetic testing is crucial. DNA Labs UAE offers a specific test for this purpose, aimed at detecting mutations in the RNASET2 gene that are associated with leukoencephalopathy cystic without megalencephaly. The test is comprehensive and designed to provide accurate results, which are essential for confirming the diagnosis and facilitating appropriate management and care for affected individuals.
The cost of the test is 4400 AED, reflecting the specialized nature of the testing and the expertise required to interpret the results. Conducted in a state-of-the-art laboratory by professionals experienced in genetic diagnostics, this test represents a crucial step for families seeking answers about this rare condition. By confirming the genetic basis of the disease, it also opens the door to genetic counseling and discussions about the risk of recurrence in future pregnancies.
